Cellular and T cell engager Immunotherapy
Updated Comparative Effectiveness of Talquetamab vs Real-world Physician’s Choice of Treatment in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Jing Christine Ye, MD, MSc
Associate Professor
UT MD Anderson Cancer Center, TX, USA (currently); University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA (during study), United States